期刊文献+

心力衰竭加重并左室射血分数降低患者的QRS时限与预后 被引量:4

The prognostic value of QRS duration in heart failure patients with reduced ejection fraction
暂未订购
导出
摘要 目的观察住院期间QRs时限对心力衰竭并左室射血分数降低预后的影响。方法回顾性分析心力衰竭并左室射血分数降低(≤40%)或正常的住院患者住院期间的QRs波群时限。结果3002例患者纳入研究,其中正常QRS波群时限1745例(〈120ms),QRS波群延长(≥120ms)1257例。平均随访10个月,基础QRS波群时限正常患者全因死亡率为18.8%,基础QRS波群延长患者为28.3%(nR。1.62,95%CIL38~1.88)。基础QRS波群正常患者心血管死亡和心力衰竭住院率为31.5%和35.8%,延长者则为39.0%和43.6%(朋=1.40、1.42;95%CIL25-1.60、1.18-1.72)。QRS波群时限延长与增加全因死亡率危险性相关(HR=1.25:95%C11.03~1.52),并增加心血管死亡或心力衰竭住院率(HR=1.21、1.28,95%CIL10~1.40、1.12~1.38)。基础Qas波群延长患者最后住院心电图QRS波群正常者仅为4.0%。结论延长的QRS波群在LVEF降低患者中十分多见,是出院后高患病率和高死亡率的独立预测因素。 Objective To observe the influence of QRS duration on the prognosis of heart failure patients with reduced left ventricular ejection fraction. Methods A retrospective analysis of inhospital patients with heart failure and reduced (≤40%) or normal left ventricular ejection fraction was done to analyze the QRS wave dura- tion. Results The 3002 patients included in the study included 1745 cases with normal QRS wave duration(〈120 ms) and 1257 eases with prolonged QRS wave( ≥ 120 ms). The mean follow-up time was 10 months, patients with normal QRS duration showed a all-cause mortality of 18.8% and those with prolonged QRS wave had a mortality of 28.3% (HR= 1.62, 95%C1 1.38-1.88). Cardiovascular death or heart failure hospitalization of patients with normal and prolonged QRS wave groups were 31.5%, 35.8% vs 39.0%, 43.6% (HR=1.40, 1.42; 95%CI 1.25-1.60, 1.18- 1.72) respectively. QRS duration prolongation correlated with increased all-cause mortality (HR =1.25; 95% CI 1.03-1.52) and cardiovascular death or heart failure hospitalization (HR=1.21, 1.28, 95%CI 1.10-1.40, 1.12- 1.38 ). At the last hospitalization time the normal QRS wave was 4% in wide QRS group. Conclusion QRS pro- longation in patients with reduced LVEF is an independent predictor of morbility and mortality.
出处 《中国心血管病研究》 CAS 2013年第5期341-344,共4页 Chinese Journal of Cardiovascular Research
关键词 心力衰竭 左室射血分数 死亡率 患病率 QRS波群 预测 Heart failure Left ventricular ejection fraction Mortality Morbidity rate QRSwave Prediction
  • 相关文献

参考文献20

  • 1中华心血管病学分会,中华心血管病杂志编辑委员会.慢性收缩性心力衰竭治疗建议[J].中华心血管病杂志,2007,35(12):1073.
  • 2中华医学会心血管病学分会.2007中国慢性心力衰竭诊断治疗指南.中华心血管病杂志,2007,.
  • 3急性心力衰竭诊断和治疗指南[J].中华心血管病杂志,2010,38(3):195-208. 被引量:851
  • 4卢永昕.2008年心力衰竭诊断和治疗新动向[J].临床心血管病杂志,2009,25(4):241-243. 被引量:12
  • 5Shenkman HJ, Pampati V. Congestive heart failure and QRS du- ration : Establishing Prognosis Study. Chest, 2002,122 : 528-534.
  • 6Sandhu R, Robea C. PrevMence muni hospit cohoofpients tion to le ventncular systdic 2004,93:244-246. of QRS prolongation in a corn- with heart failure and its rela- dysfunction. Am J cardiol,.
  • 7Kearney MT, Zaman A. Cardiac size, autonomic function, and 5-year follow-up of chronic heart failure patients with severe prolongation of ventricular activation. J Card Fail, 2003,9 : 93-99.
  • 8Silver H, Amin J. Prognostic implications of increased QRS dura-tion in patients with moderate and severe left ventricular systolic dysfunction. Am J Cardiol, 2001,88 : 182-185.
  • 9Borren MM, Verkerk AO. Reduced swelling-activated C1- cur- rent densities in hypertrophied ventricular myocytes of rabbits with heart failure. Cardiovasc Res, 2002,53 : 869.
  • 10郑刚.急性心力衰竭现状和预后评估的临床证据[J].中国心血管病研究,2008,6(8):561-563. 被引量:17

二级参考文献136

  • 1谢洪智,朱文玲.重组人脑利钠肽和硝酸甘油治疗急性失代偿性心力衰竭疗效和安全性的随机、开放、平行对照的多中心临床研究[J].中华心血管病杂志,2006,34(3):222-226. 被引量:228
  • 2王方正,张澍,黄德嘉,华伟,孙宝贵,沈法荣,吴书林,王建安,方全,吴立群,王景峰,王冬梅,郭涛,陈新,中华医学会心电生理和起搏分会心脏再同步治疗专家工作组.心脏再同步治疗慢性心力衰竭的建议[J].中华心律失常学杂志,2006,10(2):90-102. 被引量:91
  • 3戴锦杰.心衰患者QRS波增宽的临床意义及循证[J].实用心脑肺血管病杂志,2007,15(6):470-473. 被引量:19
  • 4中华医学会心血管病学分会 中华心血管病杂志编辑委员会.β肾上腺素能受体阻滞剂在心血管疾病应用的专家共识[J].中华心血管病杂志,2009,37:195-209.
  • 5TANG W H, FRANCIS G S. The year in heart failure[J]. JACC, 2008,52:1671-1678.
  • 6COOPER L T, BAUGHMAN K L, FELDMAN A M, et al. The role of endomyocardial biopsy in the management of cardiovascular disease[J]. Eur Heart J, 2007:28:3076--3093.
  • 7JANUZZEL J L, RICHARDS A M. An international consensus statement regarding amino-terminal pro-B- type natriuretic peptide testing: the international NT- proBNP consensus panel[J]. Am J Cardiol, 2008: 101:s25 - s28.
  • 8中华医学会心血管病学分会 中华心血管病杂志编辑委员会.慢性心力衰竭诊断治疗建议.中华心血管病杂志,2007,35(12):1076-1095.
  • 9Nieminen MS, Bohm M, Cowie MR, et al. Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: the Task Force on Acute Heart Failure of the European Society of Cardiology. Eur Heart J, 2005, 26: 384-416.
  • 10Task Force for Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of European Society of Cardiology. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008 : the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC ( HFA ) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J, 2008, 29 : 2388-2442.

共引文献4597

同被引文献39

  • 1Gencer B,Butler J,Bauer D C,et al.Association of electrocardiogram abnormalities and incident heart failure events[J].Am Heart J,2014,167(6):869.
  • 2Mc Murray J J,Adamopoulos S,Anker S D,et al.ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012[J].Eur J Heart Fail,2012,14(8):803.
  • 3黄宛.临床心电学[M].15版.北京:人民卫生出版社,2007:10.
  • 4Krüger S,Filzmaier K,Graf J,et al.QRS prolongation on surface ECG and brain natriuretic peptide as indicators of left ventricular systolic dysfunction[J].J Intern Med,2004,255(2):206.
  • 5Angelino E,Fioretti P,Miani D,et al.The Italian Mac New heart disease health-related quality of life questionnaire:a validation study[J].Intern Emerg Med,2015,10(3):359.
  • 6Gencer B,Butler J,Bauer DC,et al.Association of electrocardiogram abnormalities and incident heart failure events[J].Am Heart J,2014,167(6):869.
  • 7黄宛.临床心电学[M].北京:人民卫生出版社,2007:10.
  • 8Takama N,Koitabashi N,Ichikawa S,et al.Effects of satin therapy on cardiac sympathetic nerve activity and left ventricular remodeling in patients with chronic heart failure:a propensity score-matched analysis[J].Medicine(Baltimore),2014,93(27):e214.
  • 9Daubert MA,Massaro J,Liao L,et al.High-risk percutaneous coronary intervention is associated with reverse left ventricular remodeling and improved outcomes in patients with coronary artery disease and reduced ejection fraction[J].Am Heart J,2015,170(3):550.
  • 10Obata H,Minamino T.Cardiomyopathy:progress in diagnosis and treatments.Topics:IV.Selection of therapy for improvement of prognosis and QOL;1.Up-to-date on drug therapy for chronic heart failure[J].Nihon Naika Gakkai Zasshi,2014,103(2):378.

引证文献4

二级引证文献58

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部